FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385363080> ?p ?o ?g. }

• W4385363080 endingPage "1033" @default.
• W4385363080 startingPage "1026" @default.
• W4385363080 abstract "Patients undergoing lower extremity amputation after trauma are at high risk of venous thromboembolism. Practice variations persist regarding the optimal pharmacologic agent for venous thromboembolism prophylaxis in this patient population. We aimed to compare the efficacy of unfractionated heparin versus low-molecular-weight heparin in preventing venous thromboembolism.Using the 2013 to 2019 American College of Surgeons Pediatric Trauma Quality Improvement Program database, all trauma patients (≥18) who underwent lower limb amputation and received venous thromboembolism thromboprophylaxis in the form of unfractionated heparin or low-molecular-weight heparin were included. We excluded patients who died within 24 hours of admission or those who received no thromboprophylaxis. The primary outcome was the rate of venous thromboembolism. Multivariable logistic regression was used to evaluate the independent relationship between the type of pharmacologic prophylaxis and the risk of venous thromboembolism.A total of 4,103 patients who underwent lower extremity amputation were identified. Patients were primarily young (median age 43 years) with blunt injuries (83%). The overall rate of venous thromboembolism was 8.6%. Most (77%) patients received low-molecular-weight heparin-based prophylaxis. Compared with patients without venous thromboembolism, the venous thromboembolism cohort had a greater injury severity score (19 vs 13, P < .001), had more patients undergoing above-the-knee amputation (48% vs 36%, P < .001), and less frequently received low-molecular-weight heparin (64% vs 78%, P < .001). Multivariable analysis showed that low-molecular-weight heparin was associated with a significantly lower venous thromboembolism rate than unfractionated heparin (odds ratio: 0.65 [0.51-0.83], P < .001).Thromboprophylaxis with low-molecular-weight heparin was found to be superior to unfractionated heparin in lowering the risk of venous thromboembolism among traumatic amputees and should be the preferred pharmacologic agent in this patient population prone to venous thromboembolism." @default.
• W4385363080 created "2023-07-29" @default.
• W4385363080 creator A5017645379 @default.
• W4385363080 creator A5019303743 @default.
• W4385363080 creator A5027790043 @default.
• W4385363080 creator A5036483181 @default.
• W4385363080 creator A5050383077 @default.
• W4385363080 creator A5067484656 @default.
• W4385363080 creator A5076474814 @default.
• W4385363080 creator A5080230345 @default.
• W4385363080 creator A5086588115 @default.
• W4385363080 creator A5087224812 @default.
• W4385363080 date "2023-10-01" @default.
• W4385363080 modified "2023-10-13" @default.
• W4385363080 title "Low-molecular-weight heparin is superior to unfractionated heparin in lowering the risk of venous thromboembolism after traumatic lower extremity amputation" @default.
• W4385363080 cites W1866803133 @default.
• W4385363080 cites W1970257852 @default.
• W4385363080 cites W1981967118 @default.
• W4385363080 cites W1991312621 @default.
• W4385363080 cites W2002381836 @default.
• W4385363080 cites W2033464203 @default.
• W4385363080 cites W2042079544 @default.
• W4385363080 cites W2055698838 @default.
• W4385363080 cites W2057894852 @default.
• W4385363080 cites W2067903046 @default.
• W4385363080 cites W2081528247 @default.
• W4385363080 cites W2101874055 @default.
• W4385363080 cites W2114935503 @default.
• W4385363080 cites W2125816054 @default.
• W4385363080 cites W2160435421 @default.
• W4385363080 cites W2161375627 @default.
• W4385363080 cites W2316042705 @default.
• W4385363080 cites W2321628844 @default.
• W4385363080 cites W2322068631 @default.
• W4385363080 cites W2345688530 @default.
• W4385363080 cites W2352560204 @default.
• W4385363080 cites W2491617922 @default.
• W4385363080 cites W2558445192 @default.
• W4385363080 cites W2606711329 @default.
• W4385363080 cites W2690464869 @default.
• W4385363080 cites W2800510488 @default.
• W4385363080 cites W2802785903 @default.
• W4385363080 cites W3165767007 @default.
• W4385363080 cites W4200129414 @default.
• W4385363080 cites W4200158797 @default.
• W4385363080 cites W4292229870 @default.
• W4385363080 doi "https://doi.org/10.1016/j.surg.2023.06.036" @default.
• W4385363080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37507306" @default.
• W4385363080 hasPublicationYear "2023" @default.
• W4385363080 type Work @default.
• W4385363080 citedByCount "0" @default.
• W4385363080 crossrefType "journal-article" @default.
• W4385363080 hasAuthorship W4385363080A5017645379 @default.
• W4385363080 hasAuthorship W4385363080A5019303743 @default.
• W4385363080 hasAuthorship W4385363080A5027790043 @default.
• W4385363080 hasAuthorship W4385363080A5036483181 @default.
• W4385363080 hasAuthorship W4385363080A5050383077 @default.
• W4385363080 hasAuthorship W4385363080A5067484656 @default.
• W4385363080 hasAuthorship W4385363080A5076474814 @default.
• W4385363080 hasAuthorship W4385363080A5080230345 @default.
• W4385363080 hasAuthorship W4385363080A5086588115 @default.
• W4385363080 hasAuthorship W4385363080A5087224812 @default.
• W4385363080 hasConcept C126322002 @default.
• W4385363080 hasConcept C141071460 @default.
• W4385363080 hasConcept C156957248 @default.
• W4385363080 hasConcept C2776204877 @default.
• W4385363080 hasConcept C2776884760 @default.
• W4385363080 hasConcept C2777557582 @default.
• W4385363080 hasConcept C2780868729 @default.
• W4385363080 hasConcept C2991741193 @default.
• W4385363080 hasConcept C42219234 @default.
• W4385363080 hasConcept C71924100 @default.
• W4385363080 hasConceptScore W4385363080C126322002 @default.
• W4385363080 hasConceptScore W4385363080C141071460 @default.
• W4385363080 hasConceptScore W4385363080C156957248 @default.
• W4385363080 hasConceptScore W4385363080C2776204877 @default.
• W4385363080 hasConceptScore W4385363080C2776884760 @default.
• W4385363080 hasConceptScore W4385363080C2777557582 @default.
• W4385363080 hasConceptScore W4385363080C2780868729 @default.
• W4385363080 hasConceptScore W4385363080C2991741193 @default.
• W4385363080 hasConceptScore W4385363080C42219234 @default.
• W4385363080 hasConceptScore W4385363080C71924100 @default.
• W4385363080 hasIssue "4" @default.
• W4385363080 hasLocation W43853630801 @default.
• W4385363080 hasLocation W43853630802 @default.
• W4385363080 hasOpenAccess W4385363080 @default.
• W4385363080 hasPrimaryLocation W43853630801 @default.
• W4385363080 hasRelatedWork W1857260508 @default.
• W4385363080 hasRelatedWork W1964253022 @default.
• W4385363080 hasRelatedWork W2019564899 @default.
• W4385363080 hasRelatedWork W2073399472 @default.
• W4385363080 hasRelatedWork W2103740849 @default.
• W4385363080 hasRelatedWork W2386242011 @default.
• W4385363080 hasRelatedWork W2411295311 @default.
• W4385363080 hasRelatedWork W2417458847 @default.
• W4385363080 hasRelatedWork W2512765918 @default.
• W4385363080 hasRelatedWork W95228819 @default.
• W4385363080 hasVolume "174" @default.

• next